Literature DB >> 16565471

Iron dysregulation and neurodegeneration: the molecular connection.

Donna W Lee1, Julie K Andersen, Deepinder Kaur.   

Abstract

Iron is essential for many biological processes however excess concentrations can be harmful to many tissues. Its amounts must therefore be carefully regulated in all cells of the body including those in the brain. Increased amounts of iron have been reported in many neurodegenerative disorders. Whether this increased iron contributes to neurodegeneration has been considered controversial. In this review, we discuss some recently identified anomalies in proteins linked with iron metabolism which signify a critical role for iron dysregulation in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565471     DOI: 10.1124/mi.6.2.6

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  21 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

Authors:  Liana Lisboa Fernandez; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Clívia Miwa; Arlete Hilbig; Mônica Vianna; Nadja Schröder
Journal:  Neurotox Res       Date:  2010-12-17       Impact factor: 3.911

Review 3.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

4.  The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel.

Authors:  Xian-Ping Dong; Xiping Cheng; Eric Mills; Markus Delling; Fudi Wang; Tino Kurz; Haoxing Xu
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

5.  Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats.

Authors:  Clivia Pazin Miwa; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Raquel Mattos; Liana Lisboa Fernandez; Arlete Hilbig; Nadja Schröder; Monica R M Vianna
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

Review 6.  Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis.

Authors:  Annadurai Anandhan; Matthew Dodson; Cody J Schmidlin; Pengfei Liu; Donna D Zhang
Journal:  Cell Chem Biol       Date:  2020-04-09       Impact factor: 8.116

7.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

Authors:  Nina Lukinova; Jared Iacovelli; Tzvete Dentchev; Natalie Wolkow; Allan Hunter; Defne Amado; Gui-Shuang Ying; Janet R Sparrow; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

Review 8.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

9.  Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.

Authors:  Claudia Funke; Juergen Tomiuk; Olaf Riess; Daniela Berg; Anne S Soehn
Journal:  J Neural Transm (Vienna)       Date:  2009-05-28       Impact factor: 3.575

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.